Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cilia and flagella associated protein 46 (CFAP46) is a protein encoded by the CFAP46 gene in humans. It is characterized by tetratricopeptide repeat (TPR) domains and functions as part of the central apparatus of the cilium axoneme, where it plays a key role in the movement of cilia and flagella, as well as the structural maintenance of these organelles. Disruption of this protein affects processes dependent on ciliary motion and has been associated with inherited eye disorders, such as retinitis pigmentosa and optic atrophy. There are currently no known drug interactions, mechanisms of action, or established biomarker or safety concerns directly tied to CFAP46.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cilia and flagella associated protein 46 (CFAP46).